Fulgent Genetics, Inc. (FLGT): Cash & Equivalents
$50.19M
As of 2025-12-31
$26.30M
As of 2026-06-30
-14.2%
3-year compound annual growth
-10.5%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $50.19M | -9.0% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $55.14M | -43.4% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $97.47M | +22.6% | 2026-02-27, Balance as of period end |
| 2022-12-31 | $79.51M | -51.8% | 2025-02-28, Balance as of period end |
| 2021-12-31 | $164.89M | +88.6% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $87.43M | +630.7% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $11.96M | +77.6% | 2021-03-08, Balance as of period end |
| 2018-12-31 | $6.74M | +3.8% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $6.49M | -17.8% | 2019-03-22, Balance as of period end |
| 2016-12-31 | $7.90M | n/m | 2018-03-20, Balance as of period end |
| 2015-12-31 | $489.0K | n/a | 2017-03-17, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $50.19M | -9.0% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $495.98M | +159.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $65.43M | -43.0% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $362.58M | +51.7% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $249.73M | +16.6% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $796.27M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | $378.20M | -28.0% |
| Biodesix Inc (BDSX) | 2025-12-31 | $18.99M | -27.7% |
Compare FLGT, BLLN, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗